Lexicon Pharmaceuticals Inc (LXRX)
Fair Value-20.8% Downside
Overvalued
Analyst59.0% Upside
Market Cap1.099 B
P/E-17.9x
Yield0.0%
HealthGood
NASDAQ
Featured in
Overvalued Stocks
Rapid Revenue Growth
High-Momentum Stocks
High-Growth Small-Cap Stocks
Small-Cap Stocks
ANI Pharmaceuticals Inc (ANIP)
Fair Value36.6% Upside
Undervalued
Analyst42.9% Upside
Market Cap1.677 B
P/E16.4x
Yield0.0%
HealthGreat
NASDAQ
Featured in
Rapid Revenue Growth
Small-Cap Stocks
CorMedix Inc (CRMD)
Fair Value27.5% Upside
Undervalued
Analyst102.8% Upside
Market Cap583.7 M
P/E3.2x
Yield0.0%
HealthExcellent
NASDAQ
Featured in
Rapid Revenue Growth
High-Growth Small-Cap Stocks
Small-Cap Stocks
Harrow Health Inc (HROW)
Fair Value19.9% Upside
Undervalued
Analyst68.7% Upside
Market Cap1.507 B
P/E-101.6x
Yield0.0%
HealthGood
NASDAQ
Featured in
Rapid Revenue Growth
High-Beta Stocks
High-Beta Momentum
High-Growth Small-Cap Stocks
Small-Cap Stocks
Zevra Therapeutics Inc (ZVRA)
Fair Value9.5% Upside
Fair
Analyst119.3% Upside
Market Cap686.5 M
P/E11.8x
Yield0.0%
HealthGreat
NASDAQ
Featured in
Rapid Revenue Growth
High-Growth Small-Cap Stocks
Small-Cap Stocks
Harmony Biosciences Holdings (HRMY)
Fair Value47.2% Upside
Undervalued
Analyst18.5% Upside
Market Cap2.237 B
P/E12.6x
Yield0.0%
HealthExcellent
NASDAQ
Featured in
Rapid Revenue Growth
Xeris Pharmaceuticals Inc (XERS)
Fair Value-9.7% Downside
Fair
Analyst42.0% Upside
Market Cap1.446 B
P/E-83.4x
Yield0.0%
HealthGreat
NASDAQ
Featured in
Rapid Revenue Growth
High-Beta Stocks
High-Beta Momentum
High-Growth Small-Cap Stocks
Small-Cap Stocks
